Skip to Main Content (Press Enter)

Logo UNIMORE
  • ×
  • Home
  • Degree programmes
  • Modules
  • Jobs
  • People
  • Research Outputs
  • Academic units
  • Third Mission
  • Projects
  • Skills

UNI-FIND
Logo UNIMORE

|

UNI-FIND

unimore.it
  • ×
  • Home
  • Degree programmes
  • Modules
  • Jobs
  • People
  • Research Outputs
  • Academic units
  • Third Mission
  • Projects
  • Skills
  1. Research Outputs

Do we need high-dose therapy for initial treatment of high-risk Hodgkin's disease? Venezia New isights in Hematology

Academic Article
Publication Date:
2003
Short description:
Do we need high-dose therapy for initial treatment of high-risk Hodgkin's disease? Venezia New isights in Hematology / Federico, Massimo; Luminari, Stefano. - In: HAEMATOLOGICA. - ISSN 0390-6078. - STAMPA. - 88 suppl.10:(2003), pp. 54-55.
abstract:
no abstract
Iris type:
Articolo su rivista
Keywords:
high-dose therapy; high-risk; Hodgkin's disease.
List of contributors:
Federico, Massimo; Luminari, Stefano
Authors of the University:
LUMINARI Stefano
Handle:
https://iris.unimore.it/handle/11380/16601
Full Text:
https://iris.unimore.it//retrieve/handle/11380/16601/119660/Do%20we%20need%20high-dose......pdf
Published in:
HAEMATOLOGICA
Journal
  • Use of cookies

Powered by VIVO | Designed by Cineca | 26.4.5.0